BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34233434)

  • 1. Burden of comorbidities and medication use in childbearing women with rheumatic diseases: a nationwide population-based study.
    Chung MK; Lee CH; Park JS; Lim H; Lee J
    Korean J Intern Med; 2022 Nov; 37(6):1250-1259. PubMed ID: 34233434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
    Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication use among pregnant women with systemic lupus erythematosus and general population comparators.
    Palmsten K; Simard JF; Chambers CD; Arkema EV
    Rheumatology (Oxford); 2017 Apr; 56(4):561-569. PubMed ID: 28013193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Pregnancy Complications and Low Birth Weight Offsprings in Korean Women With Rheumatic Diseases: A Nationwide Population-Based Study.
    Park JS; Chung MK; Lim H; Lee J; Lee CH
    J Korean Med Sci; 2022 Jan; 37(2):e18. PubMed ID: 35014229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerations.
    Fedorchenko Y; Mahmudov K; Abenov Z; Zimba O; Yessirkepov M
    Rheumatol Int; 2023 Dec; 43(12):2167-2174. PubMed ID: 37718369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and prevalence of systemic lupus erythematosus among Korean women in childbearing years: A nationwide population-based study.
    Chung MK; Park JS; Lim H; Lee CH; Lee J
    Lupus; 2021 Apr; 30(4):674-679. PubMed ID: 33460342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases.
    Aaramaa HK; Mars N; Helminen M; Kerola AM; Palomäki A; Eklund KK; Gracia-Tabuenca J; Sinisalo J; FinnGen ; Isomäki P
    Semin Arthritis Rheum; 2024 Apr; 65():152382. PubMed ID: 38308930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Mok CC; Ho LY; Tse SM; Chan KL; To CH
    Clin Rheumatol; 2023 Apr; 42(4):1019-1026. PubMed ID: 36385600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.
    Joo YB; Sung YK; Shim JS; Kim JH; Lee EK; Lee HS; Bae SC
    Rheumatol Int; 2015 May; 35(5):879-86. PubMed ID: 25300729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions.
    Desai RJ; Huybrechts KF; Bateman BT; Hernandez-Diaz S; Mogun H; Gopalakrishnan C; Patorno E; Kim SC
    Arthritis Rheumatol; 2016 May; 68(5):1183-9. PubMed ID: 26606742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in Children Born to Women with Rheumatic Diseases.
    Vinet É; Bernatsky S
    Rheum Dis Clin North Am; 2017 May; 43(2):263-273. PubMed ID: 28390568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcomes in women with rheumatic diseases: a real-world observational study in Japan.
    Sugawara E; Kato M; Fujieda Y; Oku K; Bohgaki T; Yasuda S; Umazume T; Morikawa M; Watari H; Atsumi T
    Lupus; 2019 Oct; 28(12):1407-1416. PubMed ID: 31551035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics of patients with rheumatic diseases and abnormal liver function].
    Wu CY; Li MC; Duan XW; Li HB; Wang YH; Li Q; Luo H; Xu J; Wu LJ; Wang YF; Zhao C; Fang YF; Lin SD; Xu D; Tian XP; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1102-1113. PubMed ID: 37650184
    [No Abstract]   [Full Text] [Related]  

  • 15. A systematic comparison of rheumatoid arthritis and ankylosing spondylitis: non-steroidal anti-inflammatory drugs.
    Poddubnyy D; Song IH; Sieper J
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S148-51. PubMed ID: 19822063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of rheumatoid arthritis and ankylosing spondylitis.
    Braun J; Sieper J
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S146-7. PubMed ID: 19822062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff.
    Alves de Oliveira Junior H; Pereira da Veiga T; Acurcio FA; Almeida AM; Ribeiro Dos Santos JB; da Silva MRR; Kakehasi AM; Cherchiglia ML
    Hosp Pract (1995); 2020 Oct; 48(4):213-222. PubMed ID: 32567403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of rheumatic diseases in central Greece: a population survey.
    Anagnostopoulos I; Zinzaras E; Alexiou I; Papathanasiou AA; Davas E; Koutroumpas A; Barouta G; Sakkas LI
    BMC Musculoskelet Disord; 2010 May; 11():98. PubMed ID: 20504294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for herpes zoster in patients with rheumatic diseases: a nationwide cohort study in Korea.
    Ryu HJ; Han JO; Lee SA; Seo MR; Choi HJ; Ko KP; Baek HJ
    Rheumatology (Oxford); 2021 May; 60(5):2427-2433. PubMed ID: 33232486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.